Johnson & Johnson (JNJ) Cost of Revenue (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Cost of Revenue data on file, last reported at $8.1 billion in Q1 2026.

• Quarterly Cost of Revenue rose 10.18% year-over-year to $8.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 billion (up 9.49% YoY) and the FY2025 annual result came in at $30.3 billion, up 10.14% from the prior year.
• Cost of Revenue improved to $8.1 billion in Q1 2026 per JNJ's latest filing, from $8.0 billion in the prior quarter.
• The five-year high for Cost of Revenue was $8.1 billion in Q1 2026, with the low at $2.7 billion in Q1 2023.
• Average Cost of Revenue over 5 years is $6.9 billion, with a median of $7.0 billion recorded in 2024.
• The widest YoY moves for Cost of Revenue: up 152.15% in 2023, down 18.4% in 2023.
• Johnson & Johnson's Cost of Revenue stood at $6.2 billion in 2022, then advanced by 10.14% to $6.8 billion in 2023, then gained by 4.85% to $7.1 billion in 2024, then advanced by 11.78% to $8.0 billion in 2025, then grew by 1.73% to $8.1 billion in 2026.
• Business Quant data shows JNJ's Cost of Revenue at $8.1 billion in Q1 2026, $8.0 billion in Q4 2025, and $7.3 billion in Q3 2025.